Federal record
FDA Warning Letter issued September 9, 2025 · As of November 2026, Vial did not find a close-out letter in FDA records. Read the FDA letter →
We're providing this information based on regulatory filings Vial reviewed as of 2026-11-11. Regulatory status can change, and actions may be resolved or closed out. Confirm current status with the issuing agency: FDA.gov →
Hims & Hers
Reviewed by Vial Editorial · November 1, 2026
CA · Serves 50 states
Is this your company? Claim this profile.
Hims & Hers is a GLP-1 clinic available in all 50 states. The FDA issued a warning letter involving Hims & Hers on September 9, 2025, with no close-out letter found resolving it. Pricing starts at about $149 per month, though total cost should be confirmed before signing up.
What they offerHair LossSexual Health
Why this score?
The Vial Score measures how much of this provider's public record Vial could confirm, and how clearly the provider discloses it. It does not measure quality of care.
| 85-100 | High Confidence |
| 70-84 | Well Documented |
| 50-69 | Limited Confidence |
| 0-49 | Flagged |
Hims & Hers scores 38, in the Flagged band. The score moves when the public record changes.
Payment never changes a score.
Score history
- 38September 2026Record updated
- 87July 2026Vial scoring update
- 89June 2026Record updated: pricing
- 86June 2026Record updated
- 87June 2026Record updated
- 85May 2026Record updated
What we found on Hims & Hers
We reviewed FDA enforcement records, OIG exclusions, DEA registration, HIPAA breach records, and LegitScript certification.
The FDA issued a warning letter involving Hims & Hers on September 9, 2025. We have not found a close-out letter resolving it as of our last check (November 11, 2026); read the details below before going further. The company serves all 50 states. We also confirmed LegitScript certification. Our findings reflect public records reviewed as of November 2026.
Why this score: 5 of 5 checks complete. Each links to the public source it was verified against.
Vial describes the record, not the provider. This is not a medical recommendation or endorsement. Last reviewed November 1, 2026.
Our take
Vial EditorialBased on the records and public materials we reviewed.
Hims & Hers Health, Inc. is a San Francisco telehealth company selling prescription weight loss, testosterone and sexual health treatment through hims.com and forhers.com. Weight loss needs a membership at $39 the first month, then $149 a month, billed separately from medication that starts at $149 a month for the Wegovy pill, so about $188 the first month and about $3,466 for a year, from our research. Testosterone Rx starts at $99 a month on a 10-month plan paid upfront, and sildenafil from $4 per use. Cancel two days before renewal; the first membership fee is non-refundable and shipped medication is not refunded.
Prescribing runs through state medical groups named You Health, and the terms name six pharmacies including Apostrophe Pharmacy LLC and Curexa. The FDA issued a warning letter to Hims & Hers Health, Inc. dba Hims on September 9, 2025. We found no close-out letter for it in FDA records checked on October 28, 2026. The letter is published at https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/hims-hers-health-inc-dba-hims-716567-09092025. On Trustpilot hims.com averages 2.9 from 9,661 reviews, with membership charges without medication the leading complaint.
What it costs
Weight loss prices on hims.com and forhers.com are medication only and require the Weight Loss Membership, $39 the first month, then $149 a month, auto-renewing and billed separately. Medication starts at $149 a month for the Wegovy pill, Ozempic pill and Foundayo, $199 for the Wegovy pen and Ozempic, and $299 for Zepbound. From our research, the Wegovy pill runs about $188 the first month, then $298, so $39 plus eleven months of membership at $149 and twelve months of medication at $149, about $3,466 for a year. Testosterone Rx starts at $99 a month for a 10-month plan paid upfront, $990 at once; the homepage lists injectable TRT from $79 while the testosterone page calls it coming in 2026. Sildenafil starts at $4 per use. The first membership month is non-refundable and shipped medication is not refunded. Before paying, get the membership plus medication total at your dose in writing and confirm the product is shipping now.
Sources: hims.com · forhers.com · hims.com · hims.com · hims.com · forhers.com
What patients report
On Trustpilot hims.com averages 2.9 from 9,672 reviews with 29% at 1 star, newest October 28, 2026, and forhers.com averages 3.3 from 10,804 with 24% at 1 star, newest October 28, 2026. The BBB profile is accredited but Not Rated, with 4,522 complaints in three years and 1,303 in the past twelve months, newest October 15, 2026, and 6,004 customer reviews averaging 3.63. Praise is for medication that works, on-time delivery and an easy sign-up. Complaints repeat on being charged the $149 membership for months without medication or a provider contact, cancellation that takes several steps, and refunds refused once an order ships. The pattern is satisfied patients on the product and unhappy ones on the billing.
Sources: trustpilot.com · trustpilot.com · bbb.org · bbb.org · bbb.org · fda.gov · fda.gov · commerce.utah.gov · alston.com
What the record means
Vial scores Hims & Hers 38 out of 100, Flagged.
The FDA issued a warning letter to Hims & Hers Health, Inc. dba Hims on September 9, 2025. We found no close-out letter for it in FDA records checked on October 28, 2026. The letter is published at https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/hims-hers-health-inc-dba-hims-716567-09092025. The FDA issued a warning letter to Hims & Hers Health, Inc. dba Hers on September 9, 2025. We found no close-out letter for it in FDA records checked on October 27, 2026. The letter is published at https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/hims-hers-health-inc-dba-hers-716825-09092025. They display a LegitScript link, which we haven't checked against LegitScript's own lookup. The terms name six pharmacies, among them Apostrophe Pharmacy LLC and Curexa, and You Health medical groups. Dr. Craig Primack is named for weight loss. Testosterone products are stated as not available in all 50 states. The legal entity is Hims & Hers Health, Inc., San Francisco. Readers can search both letters on fda.gov.
Worth asking before you choose
Ask these before you sign up.
- 1What changed after the FDA warning letter?
- 2Has FDA issued a close-out letter?
- 3Are you operating as a 503A pharmacy or a 503B outsourcing facility?
- 4Which states are you licensed to ship to?
- 5Can you provide current state pharmacy license details?
See all 5 questionsShow fewer
Screenshot these or show your doctor: they’re the same questions Vial would ask.
Compare record details
REMEVi Health has no federal action found; Hims & Hers has an FDA warning letter with no close-out letter found.
Hims & Hers scores 38, REMEVi Health scores 86.
| Hims & Hers | REMEVi Health | |
|---|---|---|
| Federal actions | Confirmed | None found |
| Vial Score | 38/100 | 86/100 |
| LegitScript certified | Yes | Yes |
| States served | Nationwide (50 states) | Nationwide (50 states) |
What Vial measures, and what we don’t
We evaluate public records: federal enforcement history, registrations, certifications, and how transparent a provider is about its clinicians, pharmacies, and pricing. We don’t score bedside manner, clinical outcomes, or customer satisfaction, and we don’t collect user reviews.
Other GLP-1 providers in Vial
Other GLP-1 clinics in Vial’s directory. Open a profile, or compare side by side.
See 2 more alternativesShow fewer
Not sure where to start?Answer a few questions and we’ll narrow the directory to providers that fit.
Find your providerSide-by-side comparisons
More GLP-1 providers
Appears on: GLP-1 Telehealth Cost Comparison
This page evaluates compliance signals, not clinical outcomes. Consult a licensed physician before starting any therapy, medication, or treatment. Vial does not provide medical advice.